PainReform (PRFX) announced the receipt of partial topline data from its contract research organization, CRO, Lotus Clinical Research, for the Phase 3 clinical trial evaluating PRF-110 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback